ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm,

Unleashing the Power of Next-Generation Sequencing (NGS) in Precision Medicine

Danilo Echeverri*
Max Planck Tandem Group in Nanobioengineering, Institute of Chemistry, Faculty of Natural and Exact Sciences, University of Antioquia, Colombia
*Corresponding Author : Danilo Echeverri, Max Planck Tandem Group in Nanobioengineering, Institute of Chemistry, Faculty of Natural and Exact Sciences, University of Antioquia, Colombia, Email: Daniloecheverri465@gmail.com

Received Date: Jan 03, 2025 / Published Date: Jan 30, 2025

Abstract

Next-generation sequencing (NGS) technologies have revolutionized the field of genomics, allowing for high throughput, cost-effective, and rapid sequencing of entire genomes, exomes, and transcriptomes. In the realm of precision medicine, NGS plays a pivotal role in understanding the genetic underpinnings of diseases and enabling tailored treatments. This paper explores the transformative impact of NGS on precision medicine by focusing on its application in diagnosing genetic disorders, guiding personalized treatments, and predicting disease risk. By examining the benefits, challenges, and future potential of NGS, the paper demonstrates how this technology is unlocking new possibilities for individualized healthcare and optimizing patient outcomes

Citation: Danilo E (2025) Unleashing the Power of Next-Generation Sequencing (NGS) in Precision Medicine Clin Pharmacol Biopharm, 14: 535.

Copyright: © 2025 Danilo E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 282
  • [From(publication date): 0-0 - Jul 13, 2025]
  • Breakdown by view type
  • HTML page views: 216
  • PDF downloads: 66
Top